BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 16021158)

  • 1. Disabling pansclerotic morphea: clinical presentation in two adults.
    Maragh SH; Davis MD; Bruce AJ; Nelson AM
    J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 1):S115-9. PubMed ID: 16021158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of bosentan in treatment of unresponsive cutaneous ulceration in disabling pansclerotic morphea in children.
    Roldan R; Morote G; Castro Mdel C; Miranda MD; Moreno JC; Collantes E
    J Rheumatol; 2006 Dec; 33(12):2538-40. PubMed ID: 17143989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Incapacitating pansclerotic morphea in childhood].
    Ferrandiz C; Henkes J; González J; Peyri J
    Med Cutan Ibero Lat Am; 1981; 9(5):377-82. PubMed ID: 7038353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disabling pansclerotic morphea of childhood poses a high risk of chronic ulceration of the skin and squamous cell carcinoma.
    Wollina U; Buslau M; Heinig B; Petrov I; Unger E; Kyriopoulou E; Koch A; Köstler E; Schönlebe J; Haroske G; Doede T; Pramatarov K
    Int J Low Extrem Wounds; 2007 Dec; 6(4):291-8. PubMed ID: 18048875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disabling pansclerotic morphea of childhood--unusual case and management challenges.
    Forsea AM; Cretu AN; Ionescu R; Giurcaneanu C
    J Med Life; 2008; 1(3):348-54. PubMed ID: 20108512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower lip squamous cell carcinoma in disabling pansclerotic morphea of childhood.
    Petrov I; Gantcheva M; Miteva L; Vassileva S; Pramatarov K
    Pediatr Dermatol; 2009; 26(1):59-61. PubMed ID: 19250408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disabling pansclerotic morphea of children.
    Diaz-Perez JL; Connolly SM; Winkelmann RK
    Arch Dermatol; 1980 Feb; 116(2):169-73. PubMed ID: 7356347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic and therapeutic problems of scleroderma].
    Pogorzelska-Antkowiak A; Antkowiak R
    Wiad Lek; 2006; 59(5-6):392-5. PubMed ID: 17017489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep morphea.
    Bielsa I; Ariza A
    Semin Cutan Med Surg; 2007 Jun; 26(2):90-5. PubMed ID: 17544960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult-onset unilateral disabling pansclerotic morphea.
    Singh A; Singhal K; Choudhary S; Bisati S; Arora M
    Indian J Dermatol; 2014 May; 59(3):316. PubMed ID: 24891683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case study: periodic follow-up is necessary in morphea profunda to identify systemic evolution.
    Melani L; Cardinali C; Giomi B; Schincaglia E; Caproni M; Fabbri P
    Skinmed; 2005; 4(3):188-90. PubMed ID: 15891259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features of patients with morphea and the pansclerotic subtype: a cross-sectional study from the morphea in adults and children cohort.
    Kim A; Marinkovich N; Vasquez R; Jacobe HT
    J Rheumatol; 2014 Jan; 41(1):106-12. PubMed ID: 24293577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in the diagnosis and treatment of disabling pansclerotic morphea of childhood: case-based review.
    Soh HJ; Samuel C; Heaton V; Renton WD; Cox A; Munro J
    Rheumatol Int; 2019 May; 39(5):933-941. PubMed ID: 30838436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localized and systemic scleroderma.
    Hawk A; English JC
    Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superficial morphea: 20-year follow up in a patient with concomitant psoriasis vulgaris.
    Saleh Z; Arayssi T; Saleh Z; Ghosn S
    J Cutan Pathol; 2009 Oct; 36(10):1105-8. PubMed ID: 19602063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unilateral generalized morphea is a rare variant of localized scleroderma.
    Appelhans C; Breuckmann F; Gambichler T; Brockmeyer NH; Altmeyer P; Kreuter A
    Eur J Med Res; 2006 Apr; 11(4):152-6. PubMed ID: 16720279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Scleroderma in children: a retrospective study of 70 cases].
    Bodemer C; Belon M; Hamel-Teillac D; Amoric JC; Fraitag S; Prieur AM; De Prost Y
    Ann Dermatol Venereol; 1999 Oct; 126(10):691-4. PubMed ID: 10604006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localized scleroderma: a series of 52 patients.
    Toledano C; Rabhi S; Kettaneh A; Fabre B; Fardet L; Tiev KP; Cabane J
    Eur J Intern Med; 2009 May; 20(3):331-6. PubMed ID: 19393504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disabling pansclerotic morphoea of childhood.
    Jamalpur I; Mogili HR; Koratala A
    BMJ Case Rep; 2018 Feb; 2018():. PubMed ID: 29455178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pansclerotic morphea in childhood: a case report.
    Doede T; Wollina U; Hindermann W; Schier F; Bondartschuk M
    Pediatr Surg Int; 2003 Jul; 19(5):406-8. PubMed ID: 12827414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.